GPR81 Activation by Lactate Delays Inflammation Resolution in Acute Lung Injury
The FASEB Journal · 31.01.2026 · 40 (2)
DOI: 10.1096/fj.202501547rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 19.01.2026. Verfasst von Zhongjie Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, The Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University, Zhejiang, People's Republic of C…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Acute Lung Injury, Lactic Acid, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: MOST | National Key Research and Development Program of China (NKPs), Zhejiang Province's "Jianbing Leading Goose +X" R&D Plan, National Natural Science Foundation of China Joint Fund Project.
Abstract (Originalsprache)
Acute respiratory distress syndrome (ARDS) involves impaired macrophage function in clearing apoptotic cells. The link between clinical hyperlactatemia in ARDS patients and poor outcomes prompted this study on the immunometabolic role of lactate in disease progression. In an LPS‐induced ARDS mouse model, mice received either exogenous lactate or a lactate dehydrogenase inhibitor. Inflammatory cell infiltration was evaluated through flow cytometry and histological analysis with hematoxylin and eosin staining. Lactate signaling was confirmed in GPR81‐deficient mice. In vitro, lactate metabolism during efferocytosis was studied using primary Alveolar Macrophages (AMs). Lactate accumulation, neutrophil infiltration, and elevated inflammatory factors were observed in this ARDS model. External lactate delayed inflammation resolution and worsened lung injury. GPR81 −/− mice exhibited reduced neutrophil infiltration and better outcomes. Macrophages produced substantial amounts of lactate during efferocytosis in vitro, concurrent with upregulated expression of the glucose transporter Glut1, the lactate transporter MCT1, and the lactate receptor GPR81. Pharmacological inhibition using an LDH inhibitor, an MCT1 antagonist, or extra lactate significantly impaired efferocytic capacity. Efferocytosis triggered Myc upregulation in vitro, which was suppressed by exogenous lactate. Genetic ablation of GPR81 elevated both MCT1 and Myc expression. Silencing Myc via siRNA significantly impaired efferocytosis in vitro. These findings indicate that the activation of GPR81 by lactate delays the resolution of inflammation in acute lung injury. This effect may be attributed to the suppression of alveolar macrophage efferocytosis, which subsequently impairs the clearance of apoptotic cells and exacerbates lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, The Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China.
- Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China.
- Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Zhejiang, People's Republic of China.
- Precision Anesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Zhejiang, People's Republic of China.
ORCID-Profile: Zhongjie Liang, Shengwei Jin, Qian Wang
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- Zhejiang Province's "Jianbing Leading Goose +X" R&D Plan
- National Natural Science Foundation of China Joint Fund Project
- MOST | National Natural Science Foundation of China (NSFC)
- Zhejiang provincial medical and health science and technolog plan
- MOST | NSFC | NSFC-Zhejiang Joint Fund | | Basic Public Welfare Research Program of Zhejiang Province ()
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liang, Z., Shen, C., Zeng, J., Wei, X., Wei, J., Cao, Y., Jin, S., & Wang, Q. (2026). GPR81 Activation by Lactate Delays Inflammation Resolution in Acute Lung Injury. The FASEB Journal, 40(2). https://doi.org/10.1096/fj.202501547rr
Vancouver
Liang Z, Shen C, Zeng J, Wei X, Wei J, Cao Y, et al. GPR81 Activation by Lactate Delays Inflammation Resolution in Acute Lung Injury. The FASEB Journal. 2026;40(2). doi:10.1096/fj.202501547rr
BibTeX
@article{Liang2026,
author = {Liang, Zhongjie and Shen, Chengxi and Zeng, Junyan and Wei, Xingling and Wei, Jinling and Cao, Yuan and Jin, Shengwei and Wang, Qian},
title = {GPR81 Activation by Lactate Delays Inflammation Resolution in Acute Lung Injury},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {2},
doi = {10.1096/fj.202501547rr}
}
EUVIMED